Large-scale synthesis and characterization of p-azido-L-phenylalanine

4-azido-L-Phenylalanine (1)
To an ice cold stirred solution of 4-Amino-L-phenylalanine (1.0 g, 5.55 mmol)
in HCl (2.77 mL, 6M) was added an aq. solution of NaNO 2 solution (0.383 g, 5 .55 mmol, dissolved in 0.5 mL water) added dropwise. After the addition, the reaction mixture was stirred for 10 min in an ice bath. Additional HCl (4.6 mL, 6M) was added, followed by addition of NaN 3 solution (0.342 g, 5.3 mmol, dissolved in 1 mL water, added 0.05 mL at a time). The reaction mixture was stirred for additional 15 min, after which the ice bath was removed. The reaction mixture was allowed to stir at rt. for an hour. EtOAc (20 mL) was added and the reaction mixture was filtered. The precipitate was washed with EtOAc (3x10 mL) and dried under vacuum to give 1 (4-Azido-Lphenylalanine, 1.0 g, 87%) as light yellowish solid. 
Synthesis and purification of peptides
All the peptides were synthesized by the University of Pittsburgh Peptide Synthesis Facility. Analyticalscale separation was performed using ZORBAX reversed-phase C18 (5µm, 4.6 × 250 mm) column with UV detection at 280 nm. The column was equilibrated with 0.1% aqueous trifluoroacetic acid solution prior to each injection. Analytical separation was performed with a linear gradient of acetonitrile to 10%
in 15 min and then to 70% in 5 min in 0.1% aqueous trifluoroacetic acid with a flow rate of 1 mL/min.
The crude peptides were purified using preparative reversed-phase HPLC (XBridge C18, 5 μm, 10 x 250 mm column) eluting with a flow rate of 4 mL/min and a gradient of acetonitrile starting from 5% to 60%
in 13 min and then to 100% in 7 min in aqueous trifluoroacetic acid (0.01%). The purified peptides were first concentrated by SpeedVac concentrator followed by lyophilization. The dried peptides were resuspended in water containing 0.01% TFA and stored at -20 o C before use. Concentrations of the TAMRA-labeled acetylated peptides 2 and 5 were determined by UV absorption with ε 555 = 65000 L -1 cm -1 M -1 . Concentrations of unlabeled non-acetylated (3) and tetra-acetylated (4 and 12) histone H4 peptides as well as acetylated non-histone peptides (6) (7) (8) (9) (10) (11) were determined based on the observation that 1 mg/ml peptide generates an absorbance value (A 205 ) of 30 at 205 nm. The integrity of the purified peptide was confirmed by MALDI mass spectrometry.
Expression and purification of BRD4-BD1 and its variants in E. coli
The N-terminal 6xHis-tagged human BRD4-BD1 (first bromodomain of BRD4) expression construct pNIC28-Bsa4 (Addgene ID: 38942) and evolved Methanococcus Jannaschii p-Azido-L-phenylalanine RS (2 copies+tRNA) expression vector pEVOL-pAzF (Addgene ID: 31186) 2 were obtained from Addgene. The wild type BRD4-BD1 plasmid was transformed in to E. Coli BL21 codon plus (DE3) RIPL competent cells (Invitrogen) using pNIC28-Bsa4 kanamycin-resistant vector. 3 A single colony was picked up and grown overnight at 37 o C in 10 mL of Luria-Bertani (LB) broth in presence of 50 μg/mL kanamycin and 35 μg/mL chloramphenicol. The culture was diluted 100-fold and allowed to grow at 37 o C to an optical density
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(OD 600 ) of 0.8, and protein expression was induced overnight at 18 o C with 0.5 mM IPTG in an Innova 44®
Incubator shaker (New Brunswick Scientific). Proteins were purified as follows: harvested cells were resuspended in 15 mL lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM β-mercaptoethanol, 10%
glycerol, 25 mM imidazole, Lysozyme, DNase, and Roche protease inhibitor cocktail). The cells were lysed by pulsed sonication (Qsonica-Q700), and centrifuged at 13000 rpm for 40 min at 4 o C. The soluble extracts were subject to Ni-NTA agarose resin (Thermo) according to manufacturer's instructions. After passing 20 volumes of washing buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM β-mercaptoethanol, 10% glycerol, and 25 mM imidazole), proteins were eluted with a buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM β-mercaptoethanol, 10% glycerol, and 400 mM imidazole. Proteins were further purified by gel filtration chromatography (Superdex-75) using AKTA pure FPLC system (GE healthcare) with buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 10% glycerol. Purified proteins were concentrated using Amicon Ultra-10k centrifugal filter device (Merck Millipore Ltd.). The protein concentration was determined using Bradford assay kit (BioRad Laboratories) with BSA as a standard. The concentrated proteins were stored at -80 o C before use.
Point mutation was introduced into the pNIC28-Bsa4 BRD4-BD1 construct to generate Y97A mutant using the QuikChange Lightning site-directed mutagenesis kit (Agilent Technologies) following manufacturer's protocol using ARKTIK Thermal cycler-5020 (Thermo Scientific). The resulting mutant plasmids were confirmed by DNA sequencing. All the mutants were expressed and purified following the procedure used for wild type BRD4-BD1 protein.
The wild-type BRD4-BD1 gene in the vector was mutagenized using the QuikChange Lightning sitedirected mutagenesis kit (Agilent Technologies) to generate a series of clones with an amber suppressor codon (TAG) at positions W81, P82, F83, V87, L92, L94, Y97, C136, Y139, D144, D145, I146 and M149. The resulting mutant plasmids were confirmed by DNA sequencing. To express BRD4 variants carrying pAzido-L-phenylalanine (pAzF) at specific positions, we co-transformed E. Coli BL21 star (DE3) cells (Invitrogen) with pEVOL-pAzF and BRD4-BD1 Amber variants (W81TAG, P82TAG, F83TAG, V87TAG, L92TAG, L94TAG, Y97TAG, C136TAG, Y139TAG, D144TAG, D145TAG, I146TAG, M149TAG). Cells were recovered in 200 μL of the SOC medium for 1 h at 37 o C before being plated on a LB agar plate containing Kanamycin (Kan) (50 μg/mL) and Chloramphenicol (Cm) (35 μg/mL). A single colony was selected and grown at 37 o C in 10 mL LB broth in presence of 50 μg/mL Kan and 35 μg/mL Cm overnight.
The overnight culture was centrifuged for 10 min at 1000g. 8 mL of LB broth was subsequently removed and the cell pellet with remaining 2 mL LB broth was used to inoculate 1 L of the GMML medium supplemented with 35 μg/mL Cm and 50 μg/mL Kan. Cells were allowed to grow at 37 o C in an incubator
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shaker (225 rpm) until OD 600 reached to ~0.8. pAzF was aseptically added to the culture to a final concentration of 1 mM and the culture was cooled to 17 o C for 30 min while shaking at 225 rpm. The culture was then induced with 0.05 % arabinose and continued to shake at 17 o C for an additional 30 min. Finally, the protein expression was induced by the addition of 0.25 mM IPTG and allowed to shake at 225 rpm for 20 h at 17 o C. All the mutant proteins were purified as described above for the wild type BRD4-BD1 protein. 
Fluorescence polarization (FP) binding assay with peptides
where Y is the specific binding, B max is the maximal binding and X is the concentration of the ligand, using the SigmaPlot software. [3] For competition assays, 250 µM of unlabeled non-acetylated (3) and tetra-acetylated (4) H4 peptide and 200 nM JQ1 were separately preincubated with varying concentrations of BRD4-BD1 and its variants W81AzF, L92-AzF and M149AzF (0.3 to 800 µM) in a buffer containing 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween 20, and 0.5 mM Tris (2-carboxyethyl) phosphine (TCEP). After 30 min of incubation at room temperature, 200 nM TAMRA-labeled tetra-acetylated H4 peptide 2 was added followed by another 30 min incubation at room temperature. Fluorescence polarization was subsequently measured in a Tecan M1000 plate reader as described above. Following the same assay conditions including protein and peptide concentrations as described for the histone peptide 2, fluorescence polarization assay was performed to measure binding of BRD4-BD1 and its L92AzF mutant to (TAMRA)-labeled tetraacetylated random peptide 5. and incubated for an additional 30 min. Subsequent crosslinking, pull-down of crosslinked proteins and in-gel fluorescence were performed as described above.
Expression and purification of wild-type histone H4 and its variants
Gene sequence encoding wild type Xenopus laevis histone H4 was a kind gift from Dr. Minkui Luo at the Memorial Sloan-Kettering Cancer Center. The plasmid containing wild type Histone H4 was transformed into BL21 codon plus (DE3) RIPL competent cells. A single colony was picked up and grown overnight at 37 o C in 10 mL of LB broth with 100 μg/mL ampicillin and 35 μg/mL chloramphenicol. The inoculation culture was diluted 1:100 fold in fresh LB medium and cells were grown at 37 o C until OD 600 reached to ~0.7. Protein expression was induced by the addition of 0. Insoluble histone was recovered from inclusion bodies by dissolving in 6 M GdnHCl and 10 mM Tris-HCl pH 7.5, and incubated for 10 min at room temperature followed by centrifugation at 20,000g for 40 min at 4 o C. The soluble histone supernatant was purified by size exclusion chromatography on a Superdex-200 using AKTA pure FPLC system. Fractions were concentrated using Amicon Ultra-4 centrifugal 3K
filter and further purified with preparative reversed-phase HPLC (XBridge C18, 5 μm, 10 x 250 mm column) eluting with a flow rate of 4 mL/min starting from 10% acetonitrile to 70 % in 15 min and then to 100 % over 5 min in aqueous trifluoroacetic acid (0.01%). The purified protein was concentrated by
SpeedVac followed by lyophilization. The protein was stored at -20 o C before use. Histone H4 mutant K5C was generated by the QuikChange Lightning site-directed mutagenesis kit (Agilent Technologies) following manufacturer's protocol. The resulting mutant plasmid was confirmed by DNA sequencing.
The K5C mutant was expressed and purified as described above for the wild type Histone H4.
Chemical acetylation of cysteinylated histone H4
Purified H4 K5C (0.5 mg) was dissolved in 375 µL of 6 M GdnHCl and 200 mM sodium acetate at pH 6.0. 4 To this solution was added 75 mM glutathione, 250 mM N-vinylacetamide, 500 mM dimethylsulfide, and 250 mM of the azo radical initiator VA-044 (2,2́ -azobis[2-(2-imidazolin-2-yl) propane]dihydrochloride).
The reaction was initiated by incubating the above mixture in the dark at 37 °C for 1 h. The product was purified by RP-HPLC as described above in section 8 and characterized by ESI LC-MS.
Photo-crosslinking with full length acetylated histone H4
For photo-crosslinking experiments, 10-12 µM histone H4 Kc5Ac protein was preincubated with 100 µM of L92AzF in a buffer containing 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween 20, and 0.5 mM TCEP. After 30 min of incubation at room temperature, samples were subjected to UV irradiation at 365 nm for 30 min at 4 o C. Negative controls were not subjected to UV irradiation. Samples were then bound to Ni-NTA agarose resin and incubated for 1 h at room temperature with gentle agitation. To remove uncrosslinked H4 Kc5Ac, samples were washed with washing buffer (50 mM Tris-HCl pH 8.0, 200 mM NaCl, 5% Triton X-100) 10 times; during each washing step the samples were incubated at 60 o C for 5 min. Finally cross-linked proteins were eluted with a buffer containing 50 mM Tris-HCl pH 8.0, 150 mM S9 NaCl, 5 mM β-mercaptoethanol, and 400 mM imidazole. The eluted proteins were separated on a 4-12 % Criterion XT precast SDS-PAGE gel (Bio-Rad Laboratories) and analyzed by Western blotting.
Mammalian cell culture and cell lysis
Human embryonic kidney (HEK) 293T cells were grown in Dulbecco modified Eagle medium (DMEM) (Gibco) supplemented with 10% fetal calf serum in a humidified atmosphere containing 5% CO 2 
Photo-crosslinking with HEK293T cell lysate
For photo-crosslinking studies, ~1 mg of HEK293T cell lysates were incubated with 50 µM of BRD4-L92AzF in a buffer containing 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween 20, and 0.5 mM TCEP.
After 1 h of incubation at room temperature, the samples were subjected to UV irradiation at 365 nm 
LC-MS analysis
Intact protein analysis using capillary LC ESI-TOF: Protein samples were loaded onto a PLRP-S column using the MaxEnt algorithm resulting in a mass accuracy of 0.01%.
LC-MS/MS analysis 6
In gel trypsin digestion. In gel trypsin digestion was carried out as previously described. 22 Excised gel bands were washed with HPLC water and destained with 50% acetonitrile (ACN)/25mM ammonium bicarbonate until no visible staining. Gel pieces were dehydrated with 100% ACN, reduced with 10mM dithiothreitol (DTT) at 56°C for 1 hour, followed by alkylation with 55mM iodoacetamide (IAA) at room temperature for 45min in the dark. Gel pieces were then again dehydrated with 100% ACN to remove excess DTT and IAA, and rehydrated with 20ng/μl trypsin/25mM ammonium bicarbonate and digested overnight at 37°C. The resultant tryptic peptides were extracted with 70% ACN/5% formic acid, vacuum dried and re-constituted in18μl 0.1% formic acid. Table S1 ). While unlabeled tetra-cetylated peptide 4 and JQ1 substantially reduced the binding, peptide 3, which bears no acetyl group, had no effect on the binding. Values in parentheses represent 
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Supplementary Figure S10 : ESI LC-MS spectra of histone H4 Kc5Ac. The major peak at 11295.34 corresponds to the expected molecular weight of H4-Kc5Ac. Proteins corresponding to minor peaks observed in mass spectrum were not separable in HPLC. 
Supplementary Figure 18:
1 H NMR spectrum of 4-amino phenylalanine 
